MIRA INFORM REPORT

 

 

Report Date :

07.01.2012

 

IDENTIFICATION DETAILS

 

Name :

ICPA HEALTH PRODUCTS LIMITED

 

 

Registered Office :

233-A, Adarsh Industrial Estate, Sahar Road, Chakala, Andheri (East), Mumbai-400099, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

20.08.1983

 

 

Com. Reg. No.:

11-030670

 

 

Capital Investment / Paid-up Capital :

Rs.2.450 Millions

 

 

CIN No.:

[Company Identification No.]

U24200MH1983PLC030670

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMI04908B

 

 

PAN No.:

[Permanent Account No.]

AAACI3042F

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Drugs and Cosmetics

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba [51]

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 1890000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having fine track. Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

NOTES : Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

                                     

Country Name                       

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

233-A, Adarsh Industrial Estate, Sahar Road, Chakala, Andheri (East), Mumbai-400099, Maharashtra, India

Tel. No.:

91-22-28322379 / 28362138

Fax No.:

91-22-28216928

E-Mail :

Icpa-mumbai@icpahealth.com

icpa@bomvsnl.net.in

Website :

http://www.icpahealth.com

 

 

Plant  :

286/287, GIDC, Ankleshwar – 393002, Gujarat, India

Tel. No.:

91-2646-220765 / 221915

Fax No.:

91-2646-251708

Email :

icpank@yahoo.com

 

 

DIRECTORS

 

As on 23.09.2011

 

Name :

Mr. Rohit Gulabchand Mehta

Designation :

Managing Director

Address :

702, Shilpa Cooperative Housing Society Limited, Ramkrishna Mission Road, Santacruz [West], Mumbai – 400054, Maharashtra, India

Date of Birth/Age :

26.071947

Date of Appointment :

20.08.1983

DIN :

00145570

 

 

Name :

Ms. Abha Sajjankumar Damani

Designation :

Director

Address :

702, Shilpa Cooperative Housing Society Limited, Ramkrishna Mission Road, Santacruz [West], Mumbai – 400054, Maharashtra, India

Date of Birth/Age :

27.05.1978

Date of Appointment :

01.04.2000

DIN :

00145916

 

 

Name :

Mrs. Hiral Nimesh Chheda

Designation :

Director

Address :

6, BHikoba Niwas, Gokhale Road, Dadar [West], Mumbai – 400028, Maharashtra, India

Date of Birth/Age :

28.06.1979

Date of Appointment :

01.04.2000

DIN :

00145838

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 23.09.2011

 

Names of Shareholders

 

No. of Shares

Rohit Gulabchand Mehta

 

14310

Rohit Gulabchand Mehta

 

2800

Meena R. Mehta

 

3488

Meena R. Mehta

 

1390

Abha R Mehta

 

1234

HIral N. Chheda

 

1220

Roopa V Mehta

 

10

Vinod G Mehta

 

10

Vinod G Mehta

 

10

Nandita Y. Shah

 

10

Sejal Y. Shah

 

4

Ramilaben S. Vora

 

14

Total

 

24500

 

As on 23.09.2011

 

Equity Share Break Up

Category

Percentage

 

 

Directors or relatives of Directors

100.00

 

 

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Drugs and Cosmetics

 

 

Products :

Therapeutic Mouth Rinse Chlorhexindine Gluconate Base

Paste for Sensitive Teeth Strontium Chloride Base

Paste for Sensitive Teeth Potassium Nitrate Base

 

 

PRODUCTION STATUS [As on 31.03.2010]

 

Particulars

Unit

Actual Production

Tablets

Lakhs

182.90

Liquids

Kilolitres

494.46

Capsules

Lakha

0.00

Powders

Tonees

387.55

Injections

Lakhs

7.59

Pastes and Cream

Tonnes

551.35

Soap

Lakhs

0.00

 

Note :

 

  1. Capacities are interchangeable and hence can not be stated separately.

 

  1. Production of finished goods includes goods sent for clinical trails

 

  1. Quantity details of production includes figures in respect of injection, liquids and tablets for which part of the production process is carried out with third parties under company’s supervision and control on loan license basis

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

  • Bank of India
  • Ing Vyasya Bank
  • IDBI Bank Limited

 

 

Facilities :

--

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B. S. Mehta and Company

Chartered Accountants  

Address :

11/13, Botawala Building, 2nd Floor, Horniman Circle, Mumbai – 400001, Maharashtra, India

PAN :

AAAFB1403A

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25,000

Equity Shares

Rs.100/- each

Rs.2.500 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

24,500

Equity Shares

Rs.100/- each

Rs.2.450 millions

 

 

 

 

 

Note : Of the above shares 7000 equity shares of Rs.100/- each are allotted as fully paid bonus shares by way capitalization of general reserves.


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

Particulars

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

2.450

2.450

2.450

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

470.886

388.955

309.432

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

473.336

391.405

311.882

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

3.755

3.515

3.454

 

 

 

 

TOTAL

477.091

394.920

315.336

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

75.966

77.329

70.161

Capital work-in-progress

0.000

0.000

1.581

 

 

 

 

INVESTMENT

258.955

236.233

163.170

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

53.821

42.599

47.104

 

Sundry Debtors

45.920

47.017

31.979

 

Cash & Bank Balances

22.847

16.916

24.754

 

Other Current Assets

43.203

0.000

0.000

 

Loans & Advances

22.477

19.404

16.020

Total Current Assets

188.268

125.936

119.857

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

42.330

40.629

36.066

 

Other Current Liabilities

1.918

1.914

1.919

 

Provisions

1.850

2.035

1.448

Total Current Liabilities

46.098

44.578

39.433

Net Current Assets

142.170

81.358

80.424

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

477.091

394.919

315.336

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

464.761

426.349

365.981

 

 

Sale of security [stock in trade]

30.601

0.000

0.000

 

 

Profit on futures and options [net]

0.000

4.204

0.000

 

 

Other Income

16.145

10.607

13.034

 

 

TOTAL                                     (A)

511.507

441.160

379.015

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Manufacturing Expenses

214.624

182.874

173.989

 

 

Purchase of Securities

62.199

0.000

0.000

 

 

Employee Cost

50.814

44.779

39.213

 

 

Selling and Distribution Expenses

48.057

42.538

37.501

 

 

Administrative and other  Expenses

41.559

37.003

28.038

 

 

Loss on futures and options [net]

2.554

0.000

1.853

 

 

Increase / [Decrease] in Stocks

[34.586]

6.610

[6.546]

 

 

TOTAL                                     (B)

385.221

313.804

274.048

 

 

 

 

 

 

PROFIT/[LOSS] BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

126.286

127.356

104.967

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.541

0.334

0.243

 

 

 

 

 

 

PROFIT/[LOSS] BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

125.745

127.022

104.724

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

10.627

9.358

9.642

 

 

 

 

 

 

PROFIT / [LOSS] BEFORE TAX (E-F)                 (G)

115.118

117.664

95.082

 

 

 

 

 

Less

TAX                                                                 

33.145

38.061

30.246

 

 

 

 

 

Less/ Add

Prior period adjustment [net]

[0.043]

0.080

0.084

 

 

 

 

 

 

PROFIT / [LOSS] AFTER TAX

81.930

79.523

64.752

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

371.461

291.938

227.186

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

453.391

371.461

291.938

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY - FOB Value of Export

NA

5.422

4.332

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Material and packing material and trading goods

-

25.585

27.847

 

Capital Goods

-

0.808

0.000

 

TOTAL IMPORTS

NA

26.393

27.847

 

 

 

 

 

 

Earnings/[Loss] Per Share (Rs.)

3346

3246

2643

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

16.02

18.02

17.08

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

24.77

27.60

25.98

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

43.57

57.89

34.08

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.24

0.30

0.30

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.10

0.11

0.13

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

4.08

2.82

3.04

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Operational Performance

 

The company has continued to post improved results during the year. While the gross sales have increased to Rs.480.872 millions fro that of 440.720 million in the immediately preceding financial year. The net profit before tax and prior items has marginally reduced to Rs.115.118 millions against Rs.117.664 millions in the immediately preceding financial year.

 

Outlook for the current year : the prospects for the current year appear positive and progressive in view of promising economic conditions and increasing health awareness in the people. The company is confident of achieving better results through higher market penetration both at national and international levels.

 

FIXED ASSETS :

  • Land
  • Building
  • Dies and mould
  • Effluent treatment plant
  • R and D equipment
  • Plant and Machinery
  • Furniture and Fixtures
  • Computer
  • Office Equipments
  • Electrical Installations
  • Vehicles
  • Motor Cycle
  • Refrigerator

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.78

UK Pound

1

Rs.82.33

Euro

1

Rs.68.19

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

7

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

                     

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.